Skip to content

Drug interactions

Bivalirudin + Fondaparinux

Severity: Major

Bivalirudin and Fondaparinux: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Combining a factor Xa inhibitor with a direct thrombin inhibitor produces additive anticoagulation and a higher chance of serious bleeding. It is generally unnecessary to use both.

What this interaction means in plain words

Bivalirudin and Fondaparinux can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic anticoagulation through inhibition of factor Xa (indirectly) and thrombin (directly).

What to do

Avoid overlapping use; during PCI follow guidance on the anticoagulant to use. If overlap is unavoidable, monitor for bleeding and coagulation parameters, including ACT or aPTT.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bivalirudin and Fondaparinux, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bivalirudin with Fondaparinux?

MediHelp rates the interaction as major. Bivalirudin and Fondaparinux can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Combining a factor Xa inhibitor with a direct thrombin inhibitor produces additive anticoagulation and a higher chance of serious bleeding. It is generally unnecessary to use both.

How serious is the interaction between Bivalirudin and Fondaparinux?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid overlapping use; during PCI follow guidance on the anticoagulant to use. If overlap is unavoidable, monitor for bleeding and coagulation parameters, including ACT or aPTT.

What other medicines interact with Fondaparinux?

MediHelp also lists interactions of Fondaparinux with, for example, Defibrotide, Ketorolac, Abciximab. The full list is on the Fondaparinux page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in